Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

Although the novel cytidin analogue gemcitabine has shown superior anti-tumour activity than 5-fluorouracil in advanced pancreatic cancer, further improvements of therapeutic results are warranted. This goal might be achieved by combining gemcitabine with other active drugs. This trial evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363123/
https://www.ncbi.nlm.nih.gov/pubmed/10468299
http://dx.doi.org/10.1038/sj.bjc.6690600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363123/
https://www.ncbi.nlm.nih.gov/pubmed/10468299
http://dx.doi.org/10.1038/sj.bjc.6690600

Ejemplares similares